NCCCCNCCCNC(=O)CNC(=O)CC(O)C(N)CCCC(NC(=O)C(CN)NC(=O)C(O)CNC(=O)CC(N)c1ccc(O)cc1)C(=O)O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?